USANA Health Sciences Revenue, Profits - USNA Quarterly Income Statement

Add to My Stocks
$123.95 $3.25 (2.56%) USNA stock closing price Sep 17, 2018 (Closing)

Looking at financial statements, along with the USANA Health Sciences stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 292M to 301.46M and how operating and non operating activities have impacted the USNA stock. Along with USANA Health Sciences assets and USANA Health Sciences free cash flow, USANA Health Sciences profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $33.91M and the 2018 Q2 revenue is $301.46M.

View and download details of revenue and profits for USANA Health Sciences for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
USANA Health Sciences Revenues or Net Sales
301.46M292M273.11M261.77M257.06M255.32M252.9M254.22M258.51M219.38M
Cost Of Goods Sold (COGS)49.99M49.37M45.72M47.13M43.9M42.65M46.33M44.97M45.97M42.92M
USANA Health Sciences Gross Profit
251.47M242.62M227.41M214.63M213.16M212.66M206.59M209.24M212.54M197.52M
Research & Development Expense----------
Selling General & Admin Expense200.33M199.49M191.51M183.27M180.79M179.78M174.76M173.4M175.09M164.02M
Income Before Depreciation Depletion Amortization51.14M43.12M35.91M31.35M32.36M32.88M31.85M35.83M37.44M33.5M
Depreciation Depletion Amortization----------
Non Operating Income-------0.04M---0.29M
Interest Expense----------
USANA Health Sciences Pretax Income
51.53M43.99M36.42M32.04M32.82M33.36M31.79M36.1M37.66M33M
Provision for Income Taxes17.62M15.04M42.26M8.27M9.56M12.01M9.91M6M11.9M10.7M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations33.91M28.95M-5.85M23.77M23.26M21.36M21.88M30.1M25.76M19.68M
Extraordinary Items & Discontinued Operations----------
USANA Health Sciences Profit/ Loss (Net Income)
33.91M28.95M-5.85M23.77M23.26M21.36M21.88M30.1M25.76M19.68M
Average Shares used to compute Diluted EPS24.84M24.27M24.01M24.59M25.02M24.98M25.04M25.05M24.92M26.17M
Average Shares used to compute Basic EPS24.84M24.27M24.01M24.59M25.02M24.98M25.04M25.05M24.92M26.17M
Income Before Nonrecurring Items33.91M28.95M26.94M25M24.51M22.61M21.88M30.1M25.76M19.68M
Income from Nonrecurring Items---32.79M-1.23M-1.25M-1.25M----
USANA Health Sciences Earnings Per Share Basic Net
1.361.19-0.240.970.930.860.871.201.040.75
USANA Health Sciences Earnings Per Share Diluted Net
1.361.19-0.240.970.930.860.871.201.040.75
EPS Diluted Before Nonrecurring Items1.361.191.111.020.980.910.871.201.040.75
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

USANA Health Sciences stock analysis involves checking at least a few of the important things like:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that USNA stock has a topline or revenue of $301.46M for 2018 Q2 as per this USANA Health Sciences revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $33.91M for USNA stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the USNA income statement, one can check the USANA Health Sciences historical stock prices to check how the price has moved with time.

USANA Health Sciences Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
37.79
PS Ratio (price sales ratio)
2.73
Operating Margin
17
Net Profit Margin
11.2
Dividend Yield
0%

Other Income Statements - USANA Health Sciences, Inc. Industry Peers

Mannatech income statement, Nature's Sunshine Products income statement, Nu Skin Enterprises income statement